Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
US9061031B2 · kind B2 · utility
4Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2014 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Sep 16, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions comprising retroviral vectors, transduced cells, and methods of using the same for gene therapy. In particular, the present invention relates to lentiviral vectors and cells transduced with those vectors to provide gene therapy to subjects having an adrenoleukodystrophy and/or adrenomyeloneuropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.